Finglobenewshour offers presentations made at the conferences by the leading Global Life Sciences companies. There are 300+ investor conferences held each year around the world, organized by the global investment banking companies, where a set of global life sciences companies are invited to present strategic directions about their business activities along with focus on their financial performance parameters. These presentations are placed on presenting companies’ web sites.
Our experienced team has selected and categorized these presentations available from January 1, 2016 into various categories of 25 companies so then users can obtain these presentations right away rather than going through the web sites of 2,000+ listed companies in the Global Life Sciences sector.
Coverage:
-
➢ 300+ Life Sciences Investor Conferences held globally since January 1, 2016
➢ 1,000+ Life Sciences companies who have made 3,000 presentations at these conferences this year
➢ 1,500+ of these presentations are available at company web sites
Key Benefits:
-
➢ Investor conferences presentations usually provide a strategic view to prospective investors
➢ Schedules of these conferences are not connected with the timeline of earnings releases of companies, thus new information is available (and less financial information of quarterly earnings reports included which are already published earlier)
➢ These investment conferences are attended by financial community participants who may not be regular audience of companies’ earnings calls hence presentations are prepared by presenting companies for a broader audience
➢ These conferences also have a wider sector-wide theme and presentations reflect more analytical contents of healthcare industry issues at large and how it impacts the presenting company
➢ Many of these companies present at multiple investor conferences during the year and as a result their presentations reflect further information on various questions asked at earlier conferences
Prospective Users:
-
➢ Healthcare company financial executives who are preparing investor conference presentations
➢ Investors who invest in global life sciences companies
➢ Sell-side analysts who follow global life sciences companies
➢ Mutual funds managers who specialize in healthcare stocks
➢ Strategic planning executives at global life sciences companies
➢ IR-PR advisory firms who help prepare investor presentations for global life science companies
➢ External audit firms of global life sciences companies
➢ Business schools / trade associations/ regulatory agencies focusing on global life sciences sector
Categories of Investor Presentations Available:
-
Global Pharmaceuticals
GP01 Top 25 Multinationals
GP02 Top 25 R&D
GP03 Top 25 M&A
USA/Canada
GP04 BigCap 25
GP05 MidCap 25
GP06 SmallCap 25
GP07 MicroCap 25
GP08 Europe Top 25
GP09 Asia Top 25
-
Global Biotechnology
GB-01 Top 25 Multinationals
GB02 Top 25 R&D
GB03 Top 25 M&A
USA/Canada
GB04 BigCap 25v
GB05 MidCap 25
GB06 SmallCap 25
GB07 MidCap 25
GB08 Europe Top 25
GB09 Asia Top 25
-
Global Medical Devices
GMD01 Top 25 Multinationals
GMD02 Top 25 R&D
GMD03 Top 25 M&A
USA/Canada
GMD04 BigCap 25
GMD05 MidCap 25
GMD06 SmallCap 25
GMD07 MidCap 25
GMD08 Europe Top 25
GMD09 Asia Top 25v -
Global Health Services
GHS01 Top 25 Multinationals
GHS02 Top 25 R&D
GHS03 Top 25 M&A
USA/Canada
GHS04 BigCap 25
GHS05 MidCap 25
GHS06 SmallCap 25
GHS07 MidCap 25
GHS08 Europe Top 25
GHS09 Asia Top 25